logo

Astrazeneca Plc (AZN)



Trade AZN now with
  Date
  Headline
11/17/2019 12:01:59 PM AZN : TWILIGHT Trial Shows BRILINTA Monotherapy Reduced Risk Of Relevant Bleeding Compared To Dual Antiplatelet Therapy
11/17/2019 10:52:42 AM AstraZeneca : FARXIGA Reduces Risk Of Primary Composite Outcome Of Worsening Heart Failure
11/15/2019 2:03:52 AM AstraZeneca: EC Approves Qtrilmet For The Treatment Of Type-2 Diabetes
11/14/2019 8:10:01 AM AstraZeneca Announces Launch Of Diabetes Can Break Your Heart National Movement
11/14/2019 2:10:53 AM AstraZeneca : FDA Accepts Regulatory Submission For Selumetinib In Neurofibromatosis Type 1 And Grants Priority Review
11/14/2019 2:05:33 AM AstraZeneca Says FDA Accepts NDA And Grants Priority Review For Selumetinib
11/12/2019 2:07:30 AM AstraZeneca Presents Results From Positive Phase 3 TULIP 2 Trial For Anifrolumab
11/11/2019 2:06:42 AM AstraZeneca, FibroGen Present Pooled Efficacy & CV Safety Analyses From Pivotal Phase 3 Programme Assessing Roxadustat
11/8/2019 2:02:48 AM AstraZeneca Presents Results From Phase III OLYMPUS And ROCKIES Trials
11/6/2019 10:05:07 AM AstraZeneca Says Calquence Data To Show Improved Progression-free
10/30/2019 3:04:00 AM AstraZeneca Divests Rights To Seroquel And Seroquel XR In Europe And Russia
  
 
>